Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 7,920,000 shares, a drop of 8.3% from the February 29th total of 8,640,000 shares. Based on an average trading volume of 2,210,000 shares, […]